The physiological actions of isoflavone phytoestrogens
Language English Country Czech Republic Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
20406033
DOI
10.33549/physiolres.931902
PII: 931902
Knihovny.cz E-resources
- MeSH
- Phytoestrogens chemistry therapeutic use MeSH
- Isoflavones chemistry therapeutic use MeSH
- Cardiovascular Diseases drug therapy MeSH
- Humans MeSH
- Neoplasms drug therapy MeSH
- Osteoporosis, Postmenopausal drug therapy MeSH
- Signal Transduction drug effects MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Phytoestrogens MeSH
- Isoflavones MeSH
Isoflavones are a subgroup of phytoestrogens, natural plant substances with structure similar to 17-beta-estradiol and capable of binding to estrogen receptors (ERs). Isoflavones possess higher affinity to ERbeta than to ERalpha and may have a potency to activate both genomic and non-genomic estrogen signaling pathways. In addition, isoflavones interact with the metabolism of steroid hormones. Therefore, the actions of isoflavones are rather complex and may be related to large number of factors, which are not satisfactorily identified yet. Recently, isoflavones have come into focus of interest due to several reports about their positive effect on human health, in particular prevention of hormone-dependent cancers, cardiovascular diseases, osteoporosis, adverse menopausal manifestations and age-related cognitive decline. Isoflavones may bring new insights into the mechanisms of physiological regulations and increase the possibilities of medical interventions.
References provided by Crossref.org